Pfenex (PFNX) Tops Q4 EPS by 13c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
- Sysco calls on Teamsters to end LA strike after economic deal reached
Pre-Open Stock Movers 03/07: (ARQL) (ALSK) (GWRE) Higher; (APVO) (BPI) (KR) Lower (more...)
March 7, 2019 9:26 AM ESTToday's Pre-Open Movers
Aptevo Therapeutics Inc. (Nasdaq: APVO) 43.2% LOWER; announced the pricing of (i) for a combined public offering price of $1.00 per share of common stock and related warrants, 19,850,000 shares of common stock and related warrants to purchase up to 19,850,000 shares of common stock at an exercise price of $1.30 per share, and (ii) for a combined public offering price of $0.99 per pre-funded warrant and related warrant, pre-funded warrants to purchase up to 2,150,000 shares of common stock at an exercise price of $0.01 per share and related warrants to... More



